Sponsor: 
Sanofi-Aventis Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Monovalent vaccines

Registered for use in people aged ≥2 years.

Monovalent parenteral Vi polysaccharide typhoid vaccine

Each 0.5 mL monodose pre-filled syringe contains:

  • 0.025 mg purified Vi capsular polysaccharide of Salmonella typhi strain Ty2
  • <1.25 mg phenol

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018